These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Effects of treatment with Simvastatin in elderly patients with primary hypercholesterolemia. Terranova R; Luca S Riv Eur Sci Med Farmacol; 1993; 15(3-4):163-70. PubMed ID: 7761664 [TBL] [Abstract][Full Text] [Related]
44. Simvastatin, a competitive inhibitor of HMG-CoA reductase, lowers cholesterol saturation index of gallbladder bile. Duane WC; Hunninghake DB; Freeman ML; Pooler PA; Schlasner LA; Gebhard RL Hepatology; 1988; 8(5):1147-50. PubMed ID: 3047037 [TBL] [Abstract][Full Text] [Related]
45. The conservative treatment of xanthoma of the Achilles tendon in patients affected with type IIA hypercholesterolemia. Valeo M; Dalla Vedova P; Di Giorgio L; Scarno AG; Giuliante A Chir Organi Mov; 1996; 81(3):303-10. PubMed ID: 9009414 [TBL] [Abstract][Full Text] [Related]
46. Dietary and drug treatment of severe hypercholesterolaemia. Lewis B Beitr Infusionsther; 1988; 23():39-46. PubMed ID: 2484781 [No Abstract] [Full Text] [Related]
47. Thrombocytopenic purpura during therapy with simvastatin. Possamai G; Bovo P; Santonastaso M Haematologica; 1992; 77(4):357-8. PubMed ID: 1427446 [TBL] [Abstract][Full Text] [Related]
52. HMG-CoA reductase inhibitor use in the aged. A review of clinical experience. Lintott CJ; Scott RS Drugs Aging; 1992; 2(6):518-29. PubMed ID: 1493355 [TBL] [Abstract][Full Text] [Related]
53. Hormone-replacement therapy compared with simvastatin for postmenopausal women with hypercholesterolemia. Cashin-Hemphill L; Vailas LI N Engl J Med; 1998 Jan; 338(1):63; author reply 64. PubMed ID: 9424570 [No Abstract] [Full Text] [Related]